DERM
Journey Medical Corp
Key Financials
Revenue
$61.9M
↑ 10.2%
EPS (Diluted)
$-0.47
↑ 34.7%
Total Liabilities
$62.7M
↑ 4.3%
Operating Income
$-8172000
↑ 40.3%
Net Income
$-11431000
↑ 22.1%
Total Assets
$94.6M
↑ 17.9%
Shareholders' Equity
$31.9M
↑ 58.7%
Long-term Debt
$25.3M
↑ 1.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/13/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| DEFA14A | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| 4 | 4/24/2026 | View on SEC |
| 4 | 4/24/2026 | View on SEC |
| 4 | 4/24/2026 | View on SEC |
| 8-K | 4/21/2026 | View on SEC |
| SCHEDULE 13G/A | 4/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DERM |
| Company Name | Journey Medical Corp |
| CIK | 1867066 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 480-434-6670 |